Cargando…
Determination of risk factors for drug-related problems: a multidisciplinary triangulation process
INTRODUCTION AND OBJECTIVES: Drug-related problems (DRPs) constitute a frequent safety issue among hospitalised patients leading to patient harm and increased healthcare costs. Because many DRPs are preventable, the specific risk factors that facilitate their occurrence are of considerable interest....
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368979/ https://www.ncbi.nlm.nih.gov/pubmed/25795686 http://dx.doi.org/10.1136/bmjopen-2014-006376 |
_version_ | 1782362716051079168 |
---|---|
author | Kaufmann, Carole P Stämpfli, Dominik Hersberger, Kurt E Lampert, Markus L |
author_facet | Kaufmann, Carole P Stämpfli, Dominik Hersberger, Kurt E Lampert, Markus L |
author_sort | Kaufmann, Carole P |
collection | PubMed |
description | INTRODUCTION AND OBJECTIVES: Drug-related problems (DRPs) constitute a frequent safety issue among hospitalised patients leading to patient harm and increased healthcare costs. Because many DRPs are preventable, the specific risk factors that facilitate their occurrence are of considerable interest. The objective of our study was to assess risk factors for the occurrence of DRPs with the intention to identify patients at risk for DRPs to guide and target preventive measures where they are needed most in patients. DESIGN: Triangulation process using a mixed methods approach. METHODS: We conducted an expert panel, using the nominal group technique (NGT) and a qualitative analysis, to gather risk factors for DRPs. The expert panel consisted of two consultant hospital physicians (internal medicine and geriatrics), one emergency physician, one independent general practitioner, one clinical pharmacologist, one clinical pharmacist, one registered nurse, one home care nurse and two independent community pharmacists. The literature was searched for additional risk factors. Gathered factors from the literature search and the NGT were assembled and validated in a two-round Delphi questionnaire. RESULTS: The NGT resulted in the identification of 33 items with 13 additional risk factors from the qualitative analysis of the discussion. The literature search delivered another 39 risk factors. The 85 risk factors were refined to produce 42 statements for the Delphi online questionnaire. Of these, 27 risk factors were judged to be ‘important’ or ‘rather important’. CONCLUSIONS: The gathered risk factors may help to characterise and identify patients at risk for DRPs and may enable clinical pharmacists to guide and target preventive measures in order to limit the occurrence of DRPs. As a further step, these risk factors will serve as the basis for a screening tool to identify patients at risk for DRPs. |
format | Online Article Text |
id | pubmed-4368979 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-43689792015-03-26 Determination of risk factors for drug-related problems: a multidisciplinary triangulation process Kaufmann, Carole P Stämpfli, Dominik Hersberger, Kurt E Lampert, Markus L BMJ Open Pharmacology and Therapeutics INTRODUCTION AND OBJECTIVES: Drug-related problems (DRPs) constitute a frequent safety issue among hospitalised patients leading to patient harm and increased healthcare costs. Because many DRPs are preventable, the specific risk factors that facilitate their occurrence are of considerable interest. The objective of our study was to assess risk factors for the occurrence of DRPs with the intention to identify patients at risk for DRPs to guide and target preventive measures where they are needed most in patients. DESIGN: Triangulation process using a mixed methods approach. METHODS: We conducted an expert panel, using the nominal group technique (NGT) and a qualitative analysis, to gather risk factors for DRPs. The expert panel consisted of two consultant hospital physicians (internal medicine and geriatrics), one emergency physician, one independent general practitioner, one clinical pharmacologist, one clinical pharmacist, one registered nurse, one home care nurse and two independent community pharmacists. The literature was searched for additional risk factors. Gathered factors from the literature search and the NGT were assembled and validated in a two-round Delphi questionnaire. RESULTS: The NGT resulted in the identification of 33 items with 13 additional risk factors from the qualitative analysis of the discussion. The literature search delivered another 39 risk factors. The 85 risk factors were refined to produce 42 statements for the Delphi online questionnaire. Of these, 27 risk factors were judged to be ‘important’ or ‘rather important’. CONCLUSIONS: The gathered risk factors may help to characterise and identify patients at risk for DRPs and may enable clinical pharmacists to guide and target preventive measures in order to limit the occurrence of DRPs. As a further step, these risk factors will serve as the basis for a screening tool to identify patients at risk for DRPs. BMJ Publishing Group 2015-03-20 /pmc/articles/PMC4368979/ /pubmed/25795686 http://dx.doi.org/10.1136/bmjopen-2014-006376 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Pharmacology and Therapeutics Kaufmann, Carole P Stämpfli, Dominik Hersberger, Kurt E Lampert, Markus L Determination of risk factors for drug-related problems: a multidisciplinary triangulation process |
title | Determination of risk factors for drug-related problems: a multidisciplinary triangulation process |
title_full | Determination of risk factors for drug-related problems: a multidisciplinary triangulation process |
title_fullStr | Determination of risk factors for drug-related problems: a multidisciplinary triangulation process |
title_full_unstemmed | Determination of risk factors for drug-related problems: a multidisciplinary triangulation process |
title_short | Determination of risk factors for drug-related problems: a multidisciplinary triangulation process |
title_sort | determination of risk factors for drug-related problems: a multidisciplinary triangulation process |
topic | Pharmacology and Therapeutics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368979/ https://www.ncbi.nlm.nih.gov/pubmed/25795686 http://dx.doi.org/10.1136/bmjopen-2014-006376 |
work_keys_str_mv | AT kaufmanncarolep determinationofriskfactorsfordrugrelatedproblemsamultidisciplinarytriangulationprocess AT stampflidominik determinationofriskfactorsfordrugrelatedproblemsamultidisciplinarytriangulationprocess AT hersbergerkurte determinationofriskfactorsfordrugrelatedproblemsamultidisciplinarytriangulationprocess AT lampertmarkusl determinationofriskfactorsfordrugrelatedproblemsamultidisciplinarytriangulationprocess |